Bone Therapeutics autologous
bone cell product, PREOB[sup.
Top 10 Countries for
Bone Cell Research (ranked by number of senior researchers)
Dedicated to fighting bone disease, Velcura Therapeutics has pioneered the use of human
bone cells as targets for drug discovery applications.
Velcura investigates how human
bone cells function as part of its work developing novel therapies for bone diseases such as osteoporosis.
Especially
bone cell, immune system and radiation effects research are key issues for the fight against aging and diseases and at the focus of current medical research.
builds on its patented technology and ability to rapidly isolate and analyze human
bone cells, and the company can grow human bone in tissue cultures outside the body (ex vivo) using a rapid (7-10 days) and reliable method to identify therapeutic targets aimed at stimulating human bone formation.
In their current research, the researchers found that the
bone cells produce a series of substances composed of fatty acids and amino acids called "acyl amides.
In the current experiment the effect of PREOS on
bone cell cultures will be studied at the molecular level.
a Canadian Medical Biotechnology company specialising in Skeletal Repair and Tissue Engineering, is pleased to announce that a second series of
bone cell research experiments from Canada and Europe will be flown on two of Millenium's Osteoporosis Experiments in Orbit (OSTEO(TM)) payloads aboard the NASA Shuttle Columbia mission, STS-107, scheduled for launch on January 16, 2003.
a Canadian Medical Biotechnology company specializing in Skeletal Repair and Tissue Engineering, is pleased to announce that a second series of
bone cell research experiments from Canada and Europe will be flown on two of Millenium's Osteoporosis Experiments in Orbit (OSTEO(TM)) payloads aboard the NASA Shuttle Columbia mission, STS-107, scheduled for launch on January 16, 2003.
Each lot of AlloGro(R) is then tested using the AlloSource bioassay (proliferation of human
bone cells) to ensure osteoinductive characteristics which enhance
bone cell growth.
66 by the Canadian Space Agency (CSA) to investigate
bone cell death in microgravity arising from changes in parathyroid hormone related peptide (PTHrP) expression.
